Provided by Tiger Trade Technology Pte. Ltd.

BOTANIX PHARMACEUTICALS LTD

0.112
-0.003-2.61%
Volume:405.55K
Turnover:45.01K
Market Cap:221.23M
PE:-2.39
High:0.112
Open:0.110
Low:0.110
Close:0.115
52wk High:0.535
52wk Low:0.100
Shares:1.98B
Float Shares:1.72B
Volume Ratio:0.12
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.047
EPS(LYR):-0.047
ROE:-90.93%
ROA:-42.91%
PB:2.72
PE(LYR):-2.39

Loading ...

Company Profile

Company Name:
BOTANIX PHARMACEUTICALS LTD
Exchange:
ASX
Establishment Date:
1984
Employees:
11
Office Location:
41-47 Colin Street,Suite 3,West Perth,Western Australia,Australia
Zip Code:
6005
Fax:
61 8 6210 1153
Introduction:
Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics company, develops therapeutics for serious skin diseases in Australia. It offers BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1308, a transdermal gel formulation for the treatment of plaque psoriasis; BTX 1204, a transdermal gel formation for the treatment of atopic dermatitis; BTX 1701, a novel product for mild acne; and BTX 1801, a novel antimicrobial. The company is based in North Perth, Australia.